Met-RANTES

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameMet-RANTES
Drug Alias NameMethionylated RANTESMetRANTES
ClassificationOther
Mechanisms of ActionC-C chemokine receptor type 5 antagonistsC-C chemokine receptor type 1 antagonistsImmunosuppressants
TargetsC-C chemokine receptor type 1C-C chemokine receptor type 5
Therapy Area/IndicationsAsthmaArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGeneva Biomedical Research InstituteMerck Serono
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGeneva Biomedical Research InstituteMerck Serono
Active IndicationsN/A
Inactive IndicationsAsthmaArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A